SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Residual Effects of Low-Dose Sublingual Zolpidem on Highway Driving Performance the Morning after Middle-of-the-Night Use
12 references·0 citing·43 second hop
Residual Effects of Low-Dose Sublingual Zolpidem on Highway Driving Performance the Morning after Middle-of-the-Night Use (2014)Residual Effects of Low-Dose Sublingual Z…Novel Sublingual Low-Dose Zolpidem Tablet Reduces Latency to Sleep Onset following Spontaneous Middle-of-the-Night Awakening in Insomnia in a Randomized, Double-Blind, Placebo-Controlled, Outpatient Study (2013)Novel Sublingual Low-Dose Zol…Zolpidem for insomnia (2012)Zolpidem for insomniaNext-Day Effects of Ramelteon (8 mg), Zopiclone (7.5 mg), and Placebo on Highway Driving Performance, Memory Functioning, Psychomotor Performance, and Mood in Healthy Adult Subjects (2011)Next-Day Effects of Ramelteon…Nocturnal awakenings and difficulty resuming sleep: Their burden in the European general population (2010)Nocturnal awakenings and diff…Highway driving performance and cognitive functioning the morning after bedtime and middle‐of‐the‐night use of gaboxadol, zopiclone and zolpidem (2009)Highway driving performance a…Highway Driving in the Elderly the Morning After Bedtime Use of Hypnotics (2009)Highway Driving in the Elderl…Low-Dose Sublingual Zolpidem Tartrate is Associated with Dose-Related Improvement in Sleep Onset and Duration in Insomnia Characterized by Middle-of-the-Night (MOTN) Awakenings (2008)Low-Dose Sublingual Zolpidem …Residual Effects of Hypnotics (2004)Residual Effects of HypnoticsResidual Effects of Middle-of-the-Night Administration of Zaleplon and Zolpidem on Driving Ability, Memory Functions, and Psychomotor Performance (2002)Residual Effects of Middle-of…Differential Residual Effects of Zaleplon and Zopiclone on Actual Driving: a Comparison with a Low Dose of Alcohol (2002)Differential Residual Effects…Residual effects of evening and middle-of-the-night administration of zaleplon 10 and 20 mg on memory and actual driving performance (1998)Residual effects of evening a…Comparative kinetics and dynamics of zaleplon, zolpidem, and placebo* (1998)Comparative kinetics and dyna…A manual for standardized terminology, techniques and scoring system for sleep stages in human subjects (1968)A comparison of the residual effects of zaleplon and zolpidem following administration 5 to 2 h before awakening (1999)What are the contributing factors for insomnia in the general population? (2001)Emerging drugs for insomnia: new frontiers for old and novel targets (2009)The Effect of Vestibular Stimulation in a Four-Hour Sleep Phase Advance Model of Transient Insomnia (2010)An efficacy, safety, and dose–response study of Ramelteon in patients with chronic primary insomnia (2005)Evaluation of the Efficacy and Safety of Ramelteon in Subjects with Chronic Insomnia (2007)Pharmacotherapy Treatment Options for Insomnia: A Primer for Clinicians (2015)Clinical pharmacology, efficacy, and safety of orexin receptor antagonists for the treatment of insomnia disorders (2020)Zolpidem (1990)Clinical Pharmacokinetics and Pharmacodynamics of Zolpidem (1995)Comparison of the Effects of Zaleplon, Zolpidem, and Triazolam on Memory, Learning, and Psychomotor Performance (2000)Clinically Important Drug Interactions with Zopiclone, Zolpidem and Zaleplon (2003)L’examen Clinique en Psychologie (1959)The use of analogue scales in rating subjective feelings (1974)Towards a model of stress and human performance (1983)Zolpidem Ingestion, Automatisms, and Sleep Driving: A Clinical and Legal Case Series (2011)Hypnotics in Insomnia: The Experience of Zolpidem (2014)On-the-Road Driving Performance the Morning after Bedtime Use of Suvorexant 20 and 40 mg: A Study in Non-Elderly Healthy Volunteers (2015)Zaleplon (2000)Zolpidem (2000)Residual effects of sleep medication on driving ability (2004)In the Zzz Zone: The Effects of Z-Drugs on Human Performance and Driving (2013)Insomnia in Elderly Patients: Recommendations for Pharmacological Management (2018)Prevalence, burden, and treatment of insomnia in primary care (1997)Driver sleepiness and risk of serious injury to car occupants: population based case control study (2002)Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits (2005)Zolpidem’s use for insomnia (2016)Psychopharmacology: The third generation of progress (1988)Zaleplon shortens subjective sleep latency and improves subjective sleep quality in elderly patients with insomnia (2000)Next-day residual effects of hypnotics in DSM-IV primary insomnia: a driving simulator study with simultaneous electroencephalogram monitoring (2005)Insomnia causes, consequences, and therapeutics: An overview (2003)Next-Day Residual Sedative Effect After Nighttime Administration of an Over-the-Counter Antihistamine Sleep Aid, Diphenhydramine, Measured by Positron Emission Tomography (2010)Effects of the use of hypnotics on cognition (2011)On-the-road driving performance the morning after bedtime use of suvorexant 15 and 30 mg in healthy elderly (2016)Insomnia and Its Treatment (1985)Characteristics of insomnia in the United States: results of the 1991 National Sleep Foundation Survey. I. (1999)Suvorexant for insomnia: a systematic review of the efficacy and safety profile for this newly approved hypnotic - what is the number needed to treat, number needed to harm and likelihood to be helped or harmed? (2014)Arzneimittelforschung (2015)Internet-Based Cognitive Behavioral Therapy for Insomnia (ICBT-i) Improves Comorbid Anxiety and Depression—A Meta-Analysis of Randomized Controlled Trials (2015)On-the-road driving performance the morning after bedtime administration of lemborexant in healthy adult and elderly volunteers (2018)Comparative Tolerability of Newer Agents for Insomnia (2009)The acute cognitive effects of zopiclone, zolpidem, zaleplon, and eszopiclone: A systematic review and meta-analysis (2014)
this work references cited by second hop

References

  • 2012Zolpidem for insomnia284 cited
  • 2004Residual Effects of Hypnotics278 cited
  • 2002Residual Effects of Middle-of-the-Night Administration of Zaleplon and Zolpidem on Driving Ability, Memory Functions, and Psychomotor Performance181 cited
  • 2011Next-Day Effects of Ramelteon (8 mg), Zopiclone (7.5 mg), and Placebo on Highway Driving Performance, Memory Functioning, Psychomotor Performance, and Mood in Healthy Adult Subjects137 cited
  • 2002Differential Residual Effects of Zaleplon and Zopiclone on Actual Driving: a Comparison with a Low Dose of Alcohol122 cited
  • 1998Comparative kinetics and dynamics of zaleplon, zolpidem, and placebo*115 cited
  • 2009Highway driving performance and cognitive functioning the morning after bedtime and middle‐of‐the‐night use of gaboxadol, zopiclone and zolpidem101 cited
  • 1998Residual effects of evening and middle-of-the-night administration of zaleplon 10 and 20 mg on memory and actual driving performance94 cited
  • 2009Highway Driving in the Elderly the Morning After Bedtime Use of Hypnotics59 cited
  • 2008Low-Dose Sublingual Zolpidem Tartrate is Associated with Dose-Related Improvement in Sleep Onset and Duration in Insomnia Characterized by Middle-of-the-Night (MOTN) Awakenings56 cited
  • 2013Novel Sublingual Low-Dose Zolpidem Tablet Reduces Latency to Sleep Onset following Spontaneous Middle-of-the-Night Awakening in Insomnia in a Randomized, Double-Blind, Placebo-Controlled, Outpatient Study48 cited
  • 2010Nocturnal awakenings and difficulty resuming sleep: Their burden in the European general population

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

45 cited

Cited by

No citing works inside the corpus for this window.